AU2797799A - (in vitro) model for viral infection and immune response - Google Patents

(in vitro) model for viral infection and immune response

Info

Publication number
AU2797799A
AU2797799A AU27977/99A AU2797799A AU2797799A AU 2797799 A AU2797799 A AU 2797799A AU 27977/99 A AU27977/99 A AU 27977/99A AU 2797799 A AU2797799 A AU 2797799A AU 2797799 A AU2797799 A AU 2797799A
Authority
AU
Australia
Prior art keywords
vitro
model
immune response
viral infection
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27977/99A
Inventor
Leonid B. Margolis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anticancer Inc
Original Assignee
Anticancer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anticancer Inc filed Critical Anticancer Inc
Publication of AU2797799A publication Critical patent/AU2797799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0651—Lymph nodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU27977/99A 1998-02-27 1999-03-01 (in vitro) model for viral infection and immune response Abandoned AU2797799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7634898P 1998-02-27 1998-02-27
US60076348 1998-02-27
PCT/US1999/004425 WO1999043788A1 (en) 1998-02-27 1999-03-01 In vitro model for viral infection and immune response

Publications (1)

Publication Number Publication Date
AU2797799A true AU2797799A (en) 1999-09-15

Family

ID=22131430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27977/99A Abandoned AU2797799A (en) 1998-02-27 1999-03-01 (in vitro) model for viral infection and immune response

Country Status (3)

Country Link
EP (1) EP1068298A1 (en)
AU (1) AU2797799A (en)
WO (1) WO1999043788A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032841A2 (en) * 1999-10-29 2001-05-10 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Method of in vitro t cell differentiation of cd34+ progenitor cells
GB2366294A (en) * 2000-09-01 2002-03-06 Fond Jacqueline Beytout Assay for evaluating cell responses to infection
US8071373B2 (en) 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
EP1758985B1 (en) * 2004-04-28 2015-06-03 Sanofi Pasteur VaxDesign Corporation Artificial immune system: methods for making and use
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US7771999B2 (en) 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US7785806B2 (en) 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US7785883B2 (en) 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US8030070B2 (en) 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
AU2006331504A1 (en) 2005-12-21 2007-07-05 Vaxdesign Corporation In vitro germinal centers
WO2008094178A2 (en) 2006-06-27 2008-08-07 Vaxdesign Corporation Models for vaccine assessment
US8647837B2 (en) 2007-07-16 2014-02-11 Sanofi Pasteur Vaxdesign Corp. Artificial tissue constructs comprising alveolar cells and methods for using the same
KR102292457B1 (en) * 2019-10-11 2021-08-23 오가노이드사이언스 주식회사 Method for preparing tonsil organoid comprising sTEM cell derived from tonsil and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023729A1 (en) * 1996-11-27 1998-06-04 Anticancer, Inc. In vitro model for hiv and other viral diseases

Also Published As

Publication number Publication date
WO1999043788A1 (en) 1999-09-02
EP1068298A1 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
AU2797799A (en) (in vitro) model for viral infection and immune response
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
AU6304996A (en) Vaccines against hepatitis c
AU4878096A (en) Hepatitis b vaccine
AU5047600A (en) Mammalian interleukin-10 homologs: il-d110 and il-d210
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
AU6982096A (en) Parainfluenza virus glycoproteins and vaccines
AUPO759397A0 (en) Plant and viral promoters
AU7261898A (en) Methods for viral inactivation and compositions for use in same
AU5827000A (en) Viral il-10 uses
GB9816761D0 (en) Herpesvirus preparations and their uses
AU2002359646A1 (en) Mail weighing system and method
AU2247095A (en) Cellular immune response-specific antigens and uses therefor
EP1198468A4 (en) Stabilized viral envelope proteins and uses thereof
AU1083501A (en) Antibiotic-metal complex and methods
AU4132096A (en) Compositions and methods for interfering with hepatitis b virus infection
AU3862200A (en) Rapid assay for infection in small children
AU2621401A (en) Tracheotrode and tracheal electroventilation system
AU2383300A (en) Diagonal toy pieces and their connection
GB9916794D0 (en) In vitro virus reconstitution
EP0970189A4 (en) In vitro model for hiv and other viral diseases
AU9203598A (en) Nestable mailbox and method
AU2136401A (en) P450rai-2 and related proteins
AU1224601A (en) In vitro embryo culture device and methods
AU7684000A (en) Interferon complex and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase